KJCKorea
Journal Central

@article{ART002175906},
author={Sourav Sikdar and Anisur Rahman Khuda-Bukhsh},
title={Alternative drug therapies are superior to epidermal growth factor receptor -targeted chemotherapeutic drug responses in non-small cell lung cancer},
journal={CELLMED},
issn={3022-6805},
year={2013},
volume={3},
number={2},
pages={10-10}

TY - JOUR
AU - Sourav Sikdar
AU - Anisur Rahman Khuda-Bukhsh
TI - Alternative drug therapies are superior to epidermal growth factor receptor -targeted chemotherapeutic drug responses in non-small cell lung cancer
JO - CELLMED
PY - 2013
VL - 3
IS - 2
PB - Cellmed Orthocellular Medicine and Pharmaceutical Association
SP - 10
EP - 10
SN - 3022-6805
AB - Cancer is one of the major dreaded diseases causing high mortality. Lung cancer is second in position of all cancer related deaths and mainly divided into two morphologic sub-types: small-cell lung cancer and non-small cell lung cancer (NSCLC). NSCLC is an aggressive neoplasm which hardly responds to any conventional chemotherapy. Epidermal growth factor receptor (EGFR) belongs to the ErbB family of receptor tyrosine kinase that is mainly over-expressed in NSCLC. EGFR is mainly involved in the pathogenesis and progression of different carcinoma. In vivo and in vitro studies suggest that EGFR and EGF like peptides are often over-expressed in human NSCLC and these proteins are able to induce cell transformation. The conventional therapies mostly inhibit the EGFR activity and expression level in human NSCLC with the use of some EGFR-inhibitors like HKI-272, EKB569, CL-387785 etc. and some synthetic chemotherapeutic drugs like erlotinib, gefitinib, plumbagin, docetaxel, cisplatin etc., alone or in combination of two or more drugs. These therapies selectively act by competitive inhibition of the binding of adenosine triphosphate to the tyrosine kinase domain of the EGFR, resulting in inhibition of the EGFR signaling pathway. But these chemotherapeutic drugs have some cytotoxic activities to the normal cells and have some adverse side-effects. Recent studies on some traditional alternative therapies including some herbal and plant extracts, active ingredients like curcumin, different homeopathic drugs, etc. can target EGFR-signalling in NSCLC with less toxic side-effects are being currently developed.
KW - lung cancer;non small cell lung cancer;chemotherapies;EGFR;alternative therapies
DO -
UR -
ER -

Sourav Sikdar and Anisur Rahman Khuda-Bukhsh. (2013). Alternative drug therapies are superior to epidermal growth factor receptor -targeted chemotherapeutic drug responses in non-small cell lung cancer. CELLMED, 3(2), 10-10.

Sourav Sikdar and Anisur Rahman Khuda-Bukhsh. 2013, "Alternative drug therapies are superior to epidermal growth factor receptor -targeted chemotherapeutic drug responses in non-small cell lung cancer", CELLMED, vol.3, no.2 pp.10-10.

Sourav Sikdar, Anisur Rahman Khuda-Bukhsh "Alternative drug therapies are superior to epidermal growth factor receptor -targeted chemotherapeutic drug responses in non-small cell lung cancer" CELLMED 3.2 pp.10-10 (2013) : 10.

Sourav Sikdar, Anisur Rahman Khuda-Bukhsh. Alternative drug therapies are superior to epidermal growth factor receptor -targeted chemotherapeutic drug responses in non-small cell lung cancer. 2013; 3(2), 10-10.

Sourav Sikdar and Anisur Rahman Khuda-Bukhsh. "Alternative drug therapies are superior to epidermal growth factor receptor -targeted chemotherapeutic drug responses in non-small cell lung cancer" CELLMED 3, no.2 (2013) : 10-10.

Sourav Sikdar; Anisur Rahman Khuda-Bukhsh. Alternative drug therapies are superior to epidermal growth factor receptor -targeted chemotherapeutic drug responses in non-small cell lung cancer. CELLMED, 3(2), 10-10.

Sourav Sikdar; Anisur Rahman Khuda-Bukhsh. Alternative drug therapies are superior to epidermal growth factor receptor -targeted chemotherapeutic drug responses in non-small cell lung cancer. CELLMED. 2013; 3(2) 10-10.

Sourav Sikdar, Anisur Rahman Khuda-Bukhsh. Alternative drug therapies are superior to epidermal growth factor receptor -targeted chemotherapeutic drug responses in non-small cell lung cancer. 2013; 3(2), 10-10.

Sourav Sikdar and Anisur Rahman Khuda-Bukhsh. "Alternative drug therapies are superior to epidermal growth factor receptor -targeted chemotherapeutic drug responses in non-small cell lung cancer" CELLMED 3, no.2 (2013) : 10-10.